Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD

Published:2023-03 Issue:3 Volume:81 Page:259-260
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Postalcioglu Merve,Cullaro Giuseppe,Park Meyeon

Publisher

Elsevier BV

Subject

Nephrology

Reference11 articles.

1. Tolvaptan in patients with autosomal dominant polycystic kidney disease;Torres;N Engl J Med,2012

2. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial;Torres;Nephrol Dial Transplant,2018

3. Tolvaptan in later-stage autosomal dominant polycystic kidney disease;Torres;N Engl J Med,2017

4. Clinical pattern of tolvaptan-associated liver injury in trial participants with autosomal dominant polycystic kidney disease (ADPKD): an analysis of pivotal clinical trials;Alpers;Am J Kidney Dis,2023

5. Role of liver transplantation in tolvaptan-associated acute liver failure;Endo;Kidney Int Rep,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease;Advances in Kidney Disease and Health;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP